Vestis (VSTS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
18 May, 2026Executive summary
Revenue for Q2 2026 was $659.4 million, down 0.9% year-over-year, with volume in pounds processed declining 1.2% but offset by improved pricing and product mix.
Adjusted EBITDA rose 19.1% to $74.5 million (11.3% margin), driven by operational improvements and cost control.
Net income turned positive at $2.6 million, compared to a net loss of $27.8 million in the prior year.
Transformation plan and operational excellence initiatives delivered measurable progress, including $15 million in realized cost savings year-to-date and a target of $75 million annualized by year-end.
Focused on disciplined execution, cost control, and value creation through improved culture, accountability, and commercial discipline.
Financial highlights
Adjusted EBITDA was $74.5 million (11.3% margin), up from $47.6 million (7.2% margin) in Q2 2025.
Q2 revenue was $659.4 million, down 0.9% year-over-year, with a $2.7 million FX benefit.
Adjusted Net Income for Q2 2026 was $21.8 million ($0.16 per diluted share).
Free Cash Flow for the quarter was $45.6 million; Adjusted Free Cash Flow was $56.6 million, up $63.5 million year-over-year.
Cost per pound improved by $0.02 year-over-year, driven by plant productivity and cost control.
Outlook and guidance
FY 2026 Adjusted EBITDA guidance raised to $295–$325 million (midpoint up $10 million); Free Cash Flow guidance raised to $120–$150 million (midpoint up $80 million).
Sequential Adjusted EBITDA growth of ~5% expected in Q3 and 5–10% in Q4 2026.
Fiscal 2026 revenue expected to be flat to down 2% year-over-year, excluding the 53rd week last year.
Anticipate return to top-line growth in Q4 2026.
Transformation plan expected to be substantially complete by end of fiscal 2027, with anticipated cost savings and enhanced revenue.
Latest events from Vestis
- Q1 2026 revenue fell 3% to $663.4M, with a net loss and progress on a $75M transformation plan.VSTS
Q1 202617 Apr 2026 - Q3 revenue fell 1.6% to $698M; leverage improved to 3.33x after $250M A/R facility.VSTS
Q3 20242 Feb 2026 - FY24 delivered steady results and deleveraging; FY25 targets margin expansion and growth.VSTS
Q4 202412 Jan 2026 - Q1 2025 delivered stable revenue, improved retention, and reaffirmed FY25 growth guidance.VSTS
Q1 20259 Jan 2026 - Transformation plan launched, strong governance, and no 2025 executive bonuses paid.VSTS
Proxy Filing8 Jan 2026 - Definitive Additional Materials filed under SEC Schedule 14A; no fee required.VSTS
Proxy Filing8 Jan 2026 - Transformation plan targets $75M cost savings by 2026; Q4 normalized revenue down 3.5% YoY.VSTS
Q4 20252 Dec 2025 - Shareholders will vote on directors, executive pay, and auditor, as the company advances ESG and governance.VSTS
Proxy Filing2 Dec 2025 - Additional proxy materials update shareholders ahead of the meeting, with no capital changes.VSTS
Proxy Filing2 Dec 2025